Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2011

01-09-2011 | Epidemiology

Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study

Authors: Jeanne S. Mandelblatt, Gheorghe Luta, Marilyn L. Kwan, Solomon B. Makgoeng, Isaac J. Ergas, Janise M. Roh, Barbara Sternfeld, Lucile L. Adams-Campbell, Lawrence H. Kushi

Published in: Breast Cancer Research and Treatment | Issue 2/2011

Login to get access

Abstract

Physical activity can improve quality of life (QOL) in breast cancer survivors but little is known about associations of physical activity and QOL during active cancer therapy. We examine associations between activity levels and QOL in a large cohort of breast cancer patients. Women with invasive, non-metastatic breast cancer (n = 2,279) were enrolled between 2006 and 2009 from a managed care organization; assessment were done during active therapy. A physical activity frequency questionnaire was used to calculate the average weekly metabolic equivalent task (MET) hours spent in moderate and vigorous activity during active treatment. QOL was measured by the Functional Assessment of Cancer Therapy-Breast Cancer. Linear regression models tested cross-sectional associations of QOL and functional well-being with physical activity and covariates [socio-demographics, comorbidity, body mass index (BMI), clinical variables, social support, and assessment timing]. Physical activity had a significant positive unadjusted association with all QOL sub-scales (except emotional well-being) (all P values < 0.01). Overall QOL was 4.6 points higher for women in the highest quartile of moderate and vigorous activity versus women in the lowest quartile (P < 0.001). In regression models, higher activity was associated with better overall QOL and functional well-being, controlling for covariates (P < 0.05). Increasing BMI was also independently but inversely associated with overall QOL (P < 0.001) but did not explain the relationship of activity and QOL. White women reported the higher levels of activity than minority women and activity was associated with QOL for Whites but not for minority women. Greater physical activity is associated with small but clinically meaningful increases in QOL during active breast cancer care therapy for Whites but this effect is not seen for minority women. If confirmed in longitudinal analyses, these differences may have implications for disparities research.
Literature
1.
go back to reference Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP Jr, Neugut AI, Hershman DL et al (2010) Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat 123(2):507–524PubMedCrossRef Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP Jr, Neugut AI, Hershman DL et al (2010) Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat 123(2):507–524PubMedCrossRef
2.
go back to reference Lu W, Cui Y, Chen X, Zheng Y, Gu K, Cai H et al (2009) Changes in quality of life among breast cancer patients three years post-diagnosis. Breast Cancer Res Treat 114(2):357–369PubMedCrossRef Lu W, Cui Y, Chen X, Zheng Y, Gu K, Cai H et al (2009) Changes in quality of life among breast cancer patients three years post-diagnosis. Breast Cancer Res Treat 114(2):357–369PubMedCrossRef
3.
go back to reference Avis NE, Crawford S, Manuel J (2005) Quality of life among younger women with breast cancer. J Clin Oncol 23(15):3322–3330PubMedCrossRef Avis NE, Crawford S, Manuel J (2005) Quality of life among younger women with breast cancer. J Clin Oncol 23(15):3322–3330PubMedCrossRef
4.
go back to reference Hayes SC, Rye S, Battistutta D, DiSipio T, Newman B (2010) Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes 8:92−98PubMedCrossRef Hayes SC, Rye S, Battistutta D, DiSipio T, Newman B (2010) Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes 8:92−98PubMedCrossRef
5.
go back to reference Carling M, Goodare H, Ironside A, Millington J, Rogers C (2010) Quality of life after breast radiotherapy. Lancet Oncol 11(7):612–613PubMedCrossRef Carling M, Goodare H, Ironside A, Millington J, Rogers C (2010) Quality of life after breast radiotherapy. Lancet Oncol 11(7):612–613PubMedCrossRef
6.
go back to reference McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 175(1):34–41PubMedCrossRef McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 175(1):34–41PubMedCrossRef
7.
go back to reference Galvao DA, Newton RU (2005) Review of exercise intervention studies in cancer patients. J Clin Oncol 23(4):899–909PubMedCrossRef Galvao DA, Newton RU (2005) Review of exercise intervention studies in cancer patients. J Clin Oncol 23(4):899–909PubMedCrossRef
8.
go back to reference Kwan ML, Ambrosone CB, Lee MM, Barlow J, Krathwohl SE, Ergas IJ et al (2008) The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 19(10):1065–1076PubMedCrossRef Kwan ML, Ambrosone CB, Lee MM, Barlow J, Krathwohl SE, Ergas IJ et al (2008) The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 19(10):1065–1076PubMedCrossRef
9.
go back to reference Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR et al (1997) Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15(3):974–986PubMed Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR et al (1997) Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15(3):974–986PubMed
10.
go back to reference Sternfeld B, Weltzien E, Quesenberry CP Jr, Castillo AL, Kwan M, Slattery ML et al (2009) Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev 18(1):87–95PubMedCrossRef Sternfeld B, Weltzien E, Quesenberry CP Jr, Castillo AL, Kwan M, Slattery ML et al (2009) Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev 18(1):87–95PubMedCrossRef
11.
go back to reference Staten LK, Taren DL, Howell WH, Tobar M, Poehlman ET, Hill A et al (2001) Validation of the Arizona activity frequency questionnaire using doubly labeled water. Med Sci Sports Exerc 33(11):1959–1967PubMedCrossRef Staten LK, Taren DL, Howell WH, Tobar M, Poehlman ET, Hill A et al (2001) Validation of the Arizona activity frequency questionnaire using doubly labeled water. Med Sci Sports Exerc 33(11):1959–1967PubMedCrossRef
12.
go back to reference Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–S504PubMed Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–S504PubMed
13.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef
14.
go back to reference Oehrli M, Quesenberry C, Leyden W (2006) Annual report on trends, incidence, and outcomes. Kaiser Permanente NCCR Oehrli M, Quesenberry C, Leyden W (2006) Annual report on trends, incidence, and outcomes. Kaiser Permanente NCCR
15.
go back to reference Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Pscyhol Meas 1:385–401CrossRef Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Pscyhol Meas 1:385–401CrossRef
16.
17.
go back to reference Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 23(16):3830–3842PubMedCrossRef Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 23(16):3830–3842PubMedCrossRef
18.
go back to reference Bicego D, Brown K, Ruddick M, Storey D, Wong C, Harris SR (2009) Effects of exercise on quality of life in women living with breast cancer: a systematic review. Breast J 15(1):45–51PubMedCrossRef Bicego D, Brown K, Ruddick M, Storey D, Wong C, Harris SR (2009) Effects of exercise on quality of life in women living with breast cancer: a systematic review. Breast J 15(1):45–51PubMedCrossRef
19.
go back to reference Kendall AR, Mahue-Giangreco M, Carpenter CL, Ganz PA, Bernstein L (2005) Influence of exercise activity on quality of life in long-term breast cancer survivors. Qual Life Res 14(2):361–371PubMedCrossRef Kendall AR, Mahue-Giangreco M, Carpenter CL, Ganz PA, Bernstein L (2005) Influence of exercise activity on quality of life in long-term breast cancer survivors. Qual Life Res 14(2):361–371PubMedCrossRef
20.
go back to reference Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML (2005) Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control 16(5):545–556PubMedCrossRef Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML (2005) Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control 16(5):545–556PubMedCrossRef
21.
go back to reference Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293(20):2479–2486PubMedCrossRef Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293(20):2479–2486PubMedCrossRef
22.
go back to reference Humpel N, Iverson DC (2007) Depression and quality of life in cancer survivors: is there a relationship with physical activity? Int J Behav Nutr Phys Act 4:65−75PubMedCrossRef Humpel N, Iverson DC (2007) Depression and quality of life in cancer survivors: is there a relationship with physical activity? Int J Behav Nutr Phys Act 4:65−75PubMedCrossRef
23.
go back to reference Brucker PS, Yost K, Cashy J, Webster K, Cella D (2005) General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 28(2):192–211PubMedCrossRef Brucker PS, Yost K, Cashy J, Webster K, Cella D (2005) General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 28(2):192–211PubMedCrossRef
24.
go back to reference Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS et al (2004) A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 57(9):898–910PubMedCrossRef Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS et al (2004) A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 57(9):898–910PubMedCrossRef
25.
go back to reference Ligibel JA, Partridge A, Giobbie-Hurder A, Campbell N, Shockro L, Salinadri T, Winer EP (2010) Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer. J Womens Health 19(8):1553–1559CrossRef Ligibel JA, Partridge A, Giobbie-Hurder A, Campbell N, Shockro L, Salinadri T, Winer EP (2010) Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer. J Womens Health 19(8):1553–1559CrossRef
26.
go back to reference Spence RR, Heesch KC, Brown WJ (2010) Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev 36(2):185–194PubMedCrossRef Spence RR, Heesch KC, Brown WJ (2010) Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev 36(2):185–194PubMedCrossRef
27.
go back to reference Markes M, Brockow T, Resch KL (2006) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 4:CD005001PubMed Markes M, Brockow T, Resch KL (2006) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 4:CD005001PubMed
28.
go back to reference van Waart H, Stuiver MM, van Harten WH, Sonke GS, Aaronson NK (2010) Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue. BMC Cancer 10:673−683PubMedCrossRef van Waart H, Stuiver MM, van Harten WH, Sonke GS, Aaronson NK (2010) Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue. BMC Cancer 10:673−683PubMedCrossRef
29.
go back to reference Velthuis MJ, May AM, Koppejan-Rensenbrink RA, Gijsen BC, van Breda E, de Wit GA et al (2010) Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial. BMC Cancer 10:272−281PubMedCrossRef Velthuis MJ, May AM, Koppejan-Rensenbrink RA, Gijsen BC, van Breda E, de Wit GA et al (2010) Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial. BMC Cancer 10:272−281PubMedCrossRef
30.
go back to reference Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4(2):87–100PubMedCrossRef Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4(2):87–100PubMedCrossRef
31.
go back to reference Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23(24):5814–5830PubMedCrossRef Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23(24):5814–5830PubMedCrossRef
33.
go back to reference Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D et al (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29(1):25–31PubMedCrossRef Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D et al (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29(1):25–31PubMedCrossRef
34.
go back to reference Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348(17):1625–1638PubMedCrossRef Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348(17):1625–1638PubMedCrossRef
35.
go back to reference Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B (2008) Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111(2):329–342PubMedCrossRef Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B (2008) Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111(2):329–342PubMedCrossRef
36.
go back to reference Carmichael AR, Daley AJ, Rea DW, Bowden SJ (2010) Physical activity and breast cancer outcome: a brief review of evidence, current practice and future direction. Eur J Surg Oncol 36(12):1139–1148PubMed Carmichael AR, Daley AJ, Rea DW, Bowden SJ (2010) Physical activity and breast cancer outcome: a brief review of evidence, current practice and future direction. Eur J Surg Oncol 36(12):1139–1148PubMed
37.
go back to reference Brown JC, Huedo-Medina TB, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT (2011) Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 20(1):123–133PubMedCrossRef Brown JC, Huedo-Medina TB, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT (2011) Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 20(1):123–133PubMedCrossRef
38.
39.
go back to reference Smith AW, Alfano CM, Reeve BB, Irwin ML, Bernstein L, Baumgartner K et al (2009) Race/ethnicity, physical activity, and quality of life in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 18(2):656–663PubMedCrossRef Smith AW, Alfano CM, Reeve BB, Irwin ML, Bernstein L, Baumgartner K et al (2009) Race/ethnicity, physical activity, and quality of life in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 18(2):656–663PubMedCrossRef
40.
go back to reference Sheppard VB, Christopher J, Nwabukwu I (2010) Breaking the silence barrier: opportunities to address breast cancer in African-born women. J Natl Med Assoc 102(6):461–468PubMed Sheppard VB, Christopher J, Nwabukwu I (2010) Breaking the silence barrier: opportunities to address breast cancer in African-born women. J Natl Med Assoc 102(6):461–468PubMed
41.
go back to reference Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K et al (2007) Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 106(1):85–95PubMedCrossRef Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K et al (2007) Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 106(1):85–95PubMedCrossRef
42.
go back to reference Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A et al (2003) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (arimidex, tamoxifen alone or in combination) trial efficacy and safety update analyses. Cancer 98(9):1802–1810PubMedCrossRef Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A et al (2003) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (arimidex, tamoxifen alone or in combination) trial efficacy and safety update analyses. Cancer 98(9):1802–1810PubMedCrossRef
43.
go back to reference Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N (2006) Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg 192(4):496–498PubMedCrossRef Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N (2006) Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg 192(4):496–498PubMedCrossRef
44.
go back to reference Demark-Wahnefried W, Morey MC, Sloane R, Snyder DC, Cohen HJ (2009) Promoting healthy lifestyles in older cancer survivors to improve health and preserve function. J Am Geriatr Soc 57(Suppl 2):S262–S264PubMedCrossRef Demark-Wahnefried W, Morey MC, Sloane R, Snyder DC, Cohen HJ (2009) Promoting healthy lifestyles in older cancer survivors to improve health and preserve function. J Am Geriatr Soc 57(Suppl 2):S262–S264PubMedCrossRef
45.
go back to reference Emery CF, Yang HC, Frierson GM, Peterson LJ, Suh S (2009) Determinants of physical activity among women treated for breast cancer in a 5-year longitudinal follow-up investigation. Psychooncology 18(4):377–386PubMedCrossRef Emery CF, Yang HC, Frierson GM, Peterson LJ, Suh S (2009) Determinants of physical activity among women treated for breast cancer in a 5-year longitudinal follow-up investigation. Psychooncology 18(4):377–386PubMedCrossRef
46.
go back to reference Perkins HY, Baum GP, Taylor CL, Basen-Engquist KM (2009) Effects of treatment factors, comorbidities and health-related quality of life on self-efficacy for physical activity in cancer survivors. Psychooncology 18(4):405–411PubMedCrossRef Perkins HY, Baum GP, Taylor CL, Basen-Engquist KM (2009) Effects of treatment factors, comorbidities and health-related quality of life on self-efficacy for physical activity in cancer survivors. Psychooncology 18(4):405–411PubMedCrossRef
47.
go back to reference Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66(1):5–15PubMedCrossRef Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66(1):5–15PubMedCrossRef
48.
go back to reference Patterson RE, Saquib N, Natarajan L, Rock CL, Parker BA, Thomson CA, Pierce JP (2010) Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-010-1236-x Patterson RE, Saquib N, Natarajan L, Rock CL, Parker BA, Thomson CA, Pierce JP (2010) Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Res Treat. doi:10.​1007/​s10549-010-1236-x
49.
go back to reference Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K et al (2010) Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 102(19):1468–1477PubMedCrossRef Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K et al (2010) Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 102(19):1468–1477PubMedCrossRef
50.
go back to reference Saquib N, Pierce JP, Saquib J, Flatt SW, Natarajan L, Bardwell WA et al (2011) Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors. Psychooncology 20:252–259PubMedCrossRef Saquib N, Pierce JP, Saquib J, Flatt SW, Natarajan L, Bardwell WA et al (2011) Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors. Psychooncology 20:252–259PubMedCrossRef
Metadata
Title
Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study
Authors
Jeanne S. Mandelblatt
Gheorghe Luta
Marilyn L. Kwan
Solomon B. Makgoeng
Isaac J. Ergas
Janise M. Roh
Barbara Sternfeld
Lucile L. Adams-Campbell
Lawrence H. Kushi
Publication date
01-09-2011
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2011
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1483-5

Other articles of this Issue 2/2011

Breast Cancer Research and Treatment 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine